Exelixis signs financing deals worth $160 million – BusinessWeek
By Dr. Matthew Watson
 RTT News | Exelixis signs financing deals worth $160 million BusinessWeek Biotechnology company Exelixis Inc. said Thursday it entered two financing deals for a combined $160 million. The company said it signed a deal with Silicon ... Will Exelixis Hog Limelight At ASCO?RTT News Exelixis to Raise $160 Million through Financing Transactions with Silicon ...MarketWatch (press release) |
Uncategorized
Comments Off on Exelixis signs financing deals worth $160 million – BusinessWeek |
June 4th, 2010
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research